• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors.

作者信息

Thomas Anusha S, Ma Weijie, Wang Yinghong

机构信息

University of Texas M.D. Anderson Cancer Center, Houston, TX.

Zhongnan Hospital, Wuhan, China.

出版信息

N Engl J Med. 2021 Feb 11;384(6):581-583. doi: 10.1056/NEJMc2031717.

DOI:10.1056/NEJMc2031717
PMID:33567198
Abstract
摘要

相似文献

1
Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors.优特克单抗用于治疗与免疫检查点抑制剂相关的难治性结肠炎。
N Engl J Med. 2021 Feb 11;384(6):581-583. doi: 10.1056/NEJMc2031717.
2
Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.使用白细胞介素-23阻断剂乌司奴单抗治疗慢性肉芽肿病相关结肠炎。
J Clin Immunol. 2016 Oct;36(7):619-20. doi: 10.1007/s10875-016-0318-x. Epub 2016 Jul 27.
3
Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block.在中重度溃疡性结肠炎中定位乌司奴单抗：新的竞争者。
Expert Opin Biol Ther. 2020 Apr;20(4):421-427. doi: 10.1080/14712598.2020.1727437. Epub 2020 Feb 13.
4
Ustekinumab (Stelara) for Crohn's disease.优特克单抗（喜达诺）用于治疗克罗恩病。
Med Lett Drugs Ther. 2017 Jan 2;59(1511):5-6.
5
Treatment of psoriasis with ustekinumab improved skin tightening in systemic sclerosis.使用优特克单抗治疗银屑病可改善系统性硬化症患者的皮肤紧绷状况。
Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):208-210. Epub 2017 Apr 19.
6
Ustekinumab for treating ulcerative colitis: an expert opinion.乌司奴单抗治疗溃疡性结肠炎：专家意见。
Expert Opin Biol Ther. 2020 Nov;20(11):1321-1329. doi: 10.1080/14712598.2020.1792882. Epub 2020 Jul 24.
7
Treatment of psoriasis with ustekinumab in a patient with HIV-related Kaposi sarcoma.用优特克单抗治疗一名患有HIV相关卡波西肉瘤的银屑病患者。
Clin Exp Dermatol. 2019 Jan;44(1):113-115. doi: 10.1111/ced.13630. Epub 2018 May 24.
8
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.利纳西珠单抗与乌司奴单抗治疗中重度斑块状银屑病的疗效比较。
N Engl J Med. 2017 Apr 20;376(16):1551-1560. doi: 10.1056/NEJMoa1607017.
9
Anti-interleukin 12/23 in the treatment of erythema nodosum and Crohn disease: A case report.抗白细胞介素12/23治疗结节性红斑和克罗恩病：病例报告
Dermatol Ther. 2019 Mar;32(2):e12811. doi: 10.1111/dth.12811. Epub 2019 Jan 23.
10
Positioning Ustekinumab in Crohn's Disease: From Clinical Evidence to Clinical Practice.定位乌司奴单抗在克罗恩病中的治疗地位：从临床证据到临床实践。
J Crohns Colitis. 2017 Oct 1;11(10):1258-1266. doi: 10.1093/ecco-jcc/jjx079.

引用本文的文献

1
Advances in mechanistic investigation and treatment of steroid-refractory ICI-induced liver injury.类固醇难治性免疫检查点抑制剂诱导的肝损伤的机制研究与治疗进展
Clin Exp Med. 2025 Aug 11;25(1):288. doi: 10.1007/s10238-025-01721-z.
2
Endoscopic insights into digestive-related adverse effects of immune checkpoint inhibitors: A narrative review.免疫检查点抑制剂消化系统相关不良反应的内镜观察：一项叙述性综述
World J Gastrointest Endosc. 2025 Jul 16;17(7):107798. doi: 10.4253/wjge.v17.i7.107798.
3
Gut modulation to regulate NF-κB in colorectal and gastric cancer therapy and inflammation.
肠道调节在结直肠癌和胃癌治疗及炎症中对核因子-κB的调控作用
Cancer Immunol Immunother. 2025 Jul 12;74(8):264. doi: 10.1007/s00262-025-04118-9.
4
British Society of Gastroenterology practice guidance on the management of acute and chronic gastrointestinal symptoms and complications as a result of treatment for cancer.英国胃肠病学会关于癌症治疗所致急慢性胃肠道症状及并发症管理的实践指南。
Gut. 2025 Jun 6;74(7):1040-1067. doi: 10.1136/gutjnl-2024-333812.
5
Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management.免疫检查点抑制剂治疗相关的胃肠道毒性：风险与管理
Immunotherapy. 2025 Mar;17(4):293-303. doi: 10.1080/1750743X.2025.2473305. Epub 2025 Mar 7.
6
Treatment of immune checkpoint inhibitor-related colitis: a narrative review.免疫检查点抑制剂相关结肠炎的治疗：一项叙述性综述
Transl Cancer Res. 2024 Dec 31;13(12):7002-7014. doi: 10.21037/tcr-24-2150. Epub 2024 Dec 27.
7
Double Whammy: A Case Report of Immune Checkpoint Inhibitor Colitis and Concomitant Colitis in a Patient on Nivolumab.双重打击：一例接受纳武单抗治疗患者出现免疫检查点抑制剂相关性结肠炎合并并存性结肠炎的病例报告
ACG Case Rep J. 2024 Dec 27;12(1):e01569. doi: 10.14309/crj.0000000000001569. eCollection 2025 Jan.
8
Symptomatic and Sonographic Improvement of Immune Checkpoint Inhibitor Enterocolitis With Risankizumab.使用瑞莎珠单抗治疗免疫检查点抑制剂所致小肠结肠炎的症状及超声改善情况
Inflamm Bowel Dis. 2025 Apr 10;31(4):1182-1183. doi: 10.1093/ibd/izae259.
9
JAK Inhibitor Upadacitinib Induces Remission in Refractory Immune-Related Colitis Triggered by CTLA-4 and PD-1 Inhibitor Combination Therapy in Malignant Pleural Mesothelioma: A Case Report.JAK 抑制剂乌帕替尼诱导恶性胸膜间皮瘤中 CTLA-4 和 PD-1 抑制剂联合治疗引发难治性免疫相关性结肠炎缓解：病例报告。
Cancer Rep (Hoboken). 2024 Oct;7(10):e70032. doi: 10.1002/cnr2.70032.
10
Atezolizumab-Induced Ulcerative Colitis in Patient with Hepatocellular Carcinoma: Case Report and Literature Review.阿特珠单抗致肝细胞癌患者溃疡性结肠炎：病例报告及文献复习。
Medicina (Kaunas). 2024 Aug 30;60(9):1422. doi: 10.3390/medicina60091422.